MOXIFLOXACIN AQUEOUS FORMULATION FOR PARENTERAL INTRODUCTION Russian patent published in 2013 - IPC A61K31/4709 A61K47/02 A61K47/08 A61K9/08 A61P31/04 

FIELD: medicine, pharmaceutics.

SUBSTANCE: present invention refers to chemical-pharmaceutical industry and presents a moxifloxacin aqueous formulation for parenteral introduction containing an active substance: moxifloxacin hydrochloride, water for injections and other ingredients used for parenteral introduction differing by the fact that said ingredients are presented by sodium ascorbate and sodium metabisulphite in the following proportions, g/l: moxifloxacin hydrochloride 15-25; sodium ascorbate 0.05-1; sodium metabisulphite 0.1-2; water for injections up to 1 l.

EFFECT: invention provides creating a therapeutic agent providing a high therapeutic effect in prevention and treatment of bacterial infections by reduction of infectious and inflammatory processes in tissues, and reduced length of recovery.

2 ex